Pomerantz Law Firm is investigating Pharming Group N.V. for potential securities fraud following the FDA's issuance of a Complete Response Letter rejecting the company's supplemental application for Joenja® (leniolisib) for pediatric patients. The FDA cited concerns about drug underexposure in lower weight patients and analytical method issues. The news triggered a 17.07% stock price decline on February 2, 2026.

Pharming Group received a Complete Response Letter from the FDA for its supplemental application to expand Joenja® (leniolisib) to children aged 4-11 with APDS. The FDA requested additional pediatric pharmacokinetic data to address concerns about potential underexposure in lower weight patients and clarification on analytical batch testing methods. Pharming plans to work with the FDA to address these issues and request a Type A meeting for resubmission. The existing approval for patients 12 years and older remains unaffected.

Pharming Group N.V. announced the appointment of Kenneth Lynard as Chief Financial Officer, effective October 1, 2025. Lynard brings over 20 years of global finance leadership experience in life sciences, previously serving as CFO at Schoeller Allibert, Zentiva, and holding senior roles at Gilead Sciences.

Pharming Group N.V., a global biopharmaceutical company, announces that its management team will participate in the 37th Annual Roth Conference in March 2025, where they will hold a fireside chat and be available for one-on-one meetings.

Pharming Group N.V., a global biopharmaceutical company, announces that its management team will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025.

Pharming Group N.V. announced a recommended public cash offer to acquire all outstanding shares of Abliva AB, a biotechnology company focused on developing treatments for mitochondrial diseases. Abliva's lead product, KL1333, is currently in a pivotal clinical trial and has shown positive results in a proof-of-concept study.

Pharming Group N.V., a global biopharmaceutical company, announces that its CEO will present at the Jefferies London Healthcare Conference 2024 on November 20, 2024.

Pharming Group (PHAR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session. Impinj, Inc. (NASDAQ: PI) shares rose 31% to $65.06 after the company reported better-than-expected third-quarter revenue results. Bel Fuse Inc. (NASDAQ: BELFB) surged 23.4% to $48.61 after the company reported third-quarter financial results. Endeavor Group Holdings, Inc. (NYSE: EDR) gained 22.2% to $21.65 after the company announced a review of strategic alternatives. ImmunityBio, Inc. (NASDAQ: IBRX) rose 21.7% to $1.92. The FDA accepted ImmunityBio's resubmission of its Biologics License Application for N-803 as complete. First Foundation Inc. (NYSE: FFWM) shares climbed 13.9% to $5.57 following upbeat quarterly results. Blueprint Medicines Corporation (NASDAQ: BPMC) climbed 19.4% to $52.49 following strong quarterly results. Sunnova Energy International Inc. (NYSE: NOVA) rose 17.3% to $9.40 following third-quarter results. NETGEAR, Inc. (NASDAQ: NTGR) gained 15.5% to $12.05 after the company reported better-than-expected third-quarter financial results. Pharming Group N.V. (NASDAQ: PHAR) rose 13.8% to $11.38 after the company reported a year-over-year increase in third-quarter revenue results. Eagle Bancorp, Inc. (NASDAQ: EGBN) climbed 13% to $19.97 after the company reported ...

iTeos Therapeutics, Inc. (ITOS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 80 points on Monday. Here are some big stocks recording gains in today’s session. Pitney Bowes Inc. (NYSE: PBI) gained 15.5% to $3.49 after announcing leadership transition. Jason Dies has been appointed interim Chief Executive Officer, effective immediately. Riot Platforms, Inc. (NASDAQ: RIOT) surged 13.6% to $10.60 amid an increase in the price of Bitcoin. Sphere Entertainment Co. (NYSE: SPHR) ...

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions. Synaptogenix, Inc. (NASDAQ: SNPX) surged 28.7% to $0.3610. Lifezone Metals Limited (NYSE: LZM) gained 27.4% to $15.29. Lifezone Metals recently reported H1 loss of $16.77 per share. SeqLL Inc. (NASDAQ: SQL) gained 26% to $18.04. Heart Test Laboratories, Inc. (NASDAQ: HSCS) climbed 25.2% to $0.4680. Cemtrex, Inc. (NASDAQ: CETX) rose 21.7% to $6.86. Cheche Group Inc. (NASDAQ: CCG) gained 21.1% to $17.99 amid continued volatility following the company's business combination with Prime Impact Acquisition I on Monday. The company today also said it has a successful, ongoing collaboration with Li Auto. Mondee Holdings, Inc. (NASDAQ: MOND) gained 20% to $4.1799. Mondee Holdings approved a $30 million share repurchase program to boost shareholder value. 5E Advanced Materials, Inc. (NASDAQ: FEAM) gained 20% to $2.70 after the company announced it received authorization from the Environmental Protection Agency to conduct Step-Rate Testing under its existing permit. Shattuck Labs, Inc. (NASDAQ: STTK) jumped 19.6% to $1.83. Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares rose 14.1% to $0.1169 after falling 8% on Thursday. The company recently agreed to divest AVTX-800 series. Globus Maritime Limited (NASDAQ: GLBS) gained 13.3% to $1.45. GSE Systems, ...